Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-31 @ 2:14 PM
Study NCT ID:
NCT01973660
Status:
COMPLETED
Last Update Posted:
2018-09-19
First Post:
2013-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-25
First Submit QC Date:
None
Study First Post Date:
2013-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-18
Last Update Post Date:
2018-09-19
Last Update Post Date Type:
ACTUAL